Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
Articles
Skinvisible, Inc. (SKVI) Takes Aim at the Global Skincare Market
Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products.
As Bitcoin Boom Continues, Major Players are Validating Promising Forecasts for its Limitless Value Potential
SinglePoint is very close to launching its own bitcoin exchange aimed at solving the current problems of unbankability for cannabis businesses in the United States.
Economic Impact of Biosynthesis on the Cannabis Industry
InMed Pharmaceuticals has developed a proprietary process capable of extracting all 90+ cannabinoids in a laboratory setting.
Bioabsorption Breakthrough Shows Promise for Tobacco, Cannabinoids, Medication
A noteworthy characteristic of products within this booming sector is bio-absorbability.
Grey Cloak Tech Inc. (GRCK) is “One to Watch”
Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned subsidiary Eqova Life Sciences.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Seeks to Become A ‘Global Presence’
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
Strategic Acquisition Enables Grey Cloak Tech, Inc.’s (GRCK) Development in Two Industries
On October 24, 2017, Grey Cloak Tech, Inc. announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products.
Innovative Biotechnology Companies are Transforming Cannabis-based Medical Products
These forward-thinking companies are developing proprietary systems and delivery methods to drive their research and development programs for a leading position in industry breakthroughs.
From CFN - Exclusive CEO Interview: InMed Pharmaceuticals’ Biosynthesis Platform Results in an Industry First
CFN Media sits down for an exclusive interview with InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). (VIDEO)
India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates
India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Targets Global Cannabis Market
ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
Skinvisible, Inc.’s (SKVI) Invisicare Technology Tackles Dermatology, CBD Markets
Research and development company Skinvisible, Inc. (OTCQB: SKVI) has developed Invisicare® technology, a patented polymer delivery system that improves the delivery of topically applied skin care products by enhancing the effectiveness of the active ingredients.
Skinvisible, Inc.’s (SKVI) Patented Polymer Delivery Technology Could Take CBD Products to the Next Level
Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. has a potentially wide range of applications in the cannabis market.
Biotech M&A Momentum Attractive for Cannabinoid R&D Space
With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.